Table 40 (abstract P107). Core set measures values at different time points in the 3 groups of patients (only key results are reported)
From: Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one
OFF PDN | OFF PDN | PDN ON | P value | |
|---|---|---|---|---|
Failure: No | Failure: Yes | Failure Yes or No | ||
Group 1 | Group 2 | Group 3 | ||
N = 57 | N = 24 | N = 58 | ||
Month 6: MD global | 0.5 (0–2) | 2.6 (0.8–5) | 3 (0.6–6) | <0.0001 |
Parent global | 1 (0–1.8) | 3.1 (0.5–5) | 2.5 (0.8–5.8) | 0.0002 |
CHAQ | 0.1 (0–0.5) | 0.1 (0–0.9) | 0.5 (0–1.9) | 0.0007 |
DAS | 3 (0–5) | 6.5 (1–11.5) | 8 (4–12) | <0.0001 |
CMAS | 47 (42–51) | 45 (35–48.5) | 35 (21.5–47) | 0.0001 |
CHQ-PhS | 51.8 (46.2–54.9) | 47.5 (20.3–54.1) | 36.3 (16.6–50.6) | <0.0001 |
MMT | 77 (70–80) | 70 (59–78.5) | 64 (51–75) | <0.0001 |
Month 12: MD global | 0 (0–1) | 2.6 (1–5.5) | 3 (0.6–6) | <0.0001 |
Month 18 DAS | 0 (0–3) | 6 (2.5–11.5) | 9 (2–12) | <0.0001 |
Month 24: CMAS | 50 (48–52) | 42 (36–50) | 36.5 (21.5–48) | <0.0001 |